Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1367 |
|
| Actual shortage: | 56 (4%) | |
| Anticipated shortage: | 6 (0%) | |
| Avoided shortage: | 37 (3%) | |
| Resolved: | 1268 (93%) | |
Discontinuation Reports |
291 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 287 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
211 (13%) |
|
Overdue reports |
8 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2019-06-28 | 2019-09-04 | 87965 |
| PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2019-06-28 | 2019-09-04 | 87968 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2019-07-31 | 2020-05-19 | 90464 |
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2019-11-15 | 2021-06-18 | 98811 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2021-12-08 | 2023-06-09 | 150725 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2023-08-10 | 2023-08-28 | 201548 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2024-12-04 | 2024-12-20 | 244825 |
| PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2025-11-10 | 2025-12-01 | 271432 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-24 | 2018-04-27 | 4213 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-24 | 2017-09-19 | 4216 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-04-20 | 2017-06-09 | 7373 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-06-23 | 2017-12-18 | 13709 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-09-07 | 2018-03-20 | 21562 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-06-11 | 2019-09-04 | 86225 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-06-28 | 2020-09-18 | 87959 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2019-06-28 | 2019-12-24 | 87971 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2021-11-15 | 2023-04-06 | 149254 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2022-11-11 | 2023-03-30 | 174390 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Actual shortage | 2023-04-06 | 2025-08-04 | 188954 |
| PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2023-10-02 | 2023-12-22 | 205611 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-ZOLEDRONIC ACID | 4MG | SOLUTION | Discontinued | 2017-04-07 | 2017-04-07 | 6094 |
| PMS-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117894 |
| PMS-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-07-25 | 2022-07-25 | 165469 |
| PMSC-METFORMIN | 500MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248798 |
| PMSC-METFORMIN | 850MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248801 |
| SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| TELMISARTAN | 80MG | TABLET | Discontinued | 2018-07-19 | 2021-10-27 | 56080 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| PMS-DIGOXIN | 0.250MG | TABLET | Discontinued | 2020-02-05 | 2020-02-05 | 105265 |